Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7.46x is 278% below its 2-year average of 4.19x, near the low end of its 2-year range (-18.74x–27.28x).
30.79% above its 12-month average of -10.78x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-03-31): -17.34x.
INTEREST COVERAGE RATIO
-7.46x
INTEREST COVERAGE RATIO AVG TTM
-10.78x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+30.79%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 457 covered companies
CURRENT VS SECTOR MEDIAN
-32.27%
vs the sector median at left
Cellyan Biotechnology Co., Ltd
Market Cap
$1.10M
Interest Coverage Ratio
-7.46x
TTM Avg
-10.78x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.07M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15M
Interest Coverage Ratio
-4.20x
TTM Avg
1.01x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$1.04M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.21M
Interest Coverage Ratio
-42.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.26M
Interest Coverage Ratio
-134.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$873967.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.10M | -7.46x | -10.78x | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | -290.08x | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | -4.20x | 1.01x | 1.00x | 1.00x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | -2.27x | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.21M | -42.24x | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.26M | -134.94x | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.33M | -0.41x | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | N/A | 354.05x | 372.60x | 299.52x |
| Genprex, Inc. (GNPX)vs › | $1.35M | -20.97x | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $859930.00 | N/A | N/A | N/A | N/A |
Interest Coverage
-7.5x
Debt/Equity
0.13
Current Ratio
3.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -17.34x |
| 2025-09-30 | 3.75x |
| 2025-03-31 | -18.74x |
| 2024-09-30 | 21.32x |
| 2024-03-31 | 27.28x |
| 2023-09-30 | 8.91x |
